Astrin Biosciences Expands Access to Certitude Breast Cancer Blood Test to 48 States
Astrin Biosciences has expanded access to its Certitude breast cancer blood test to 48 states through OpenLoop Health. The assay showed 92% sensitivity and 93% specificity in clinical validation.
Read More